Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.

<h4>Objective</h4>Pre- and post-operative neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) and other prognostic clinicopathological variables were correlated with progression free survival (PFS) and overall survival (OS) of Glioblastoma Multiforme (GBM) patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Celine Garrett, Therese M Becker, David Lynch, Joseph Po, Wei Xuan, Kieran F Scott, Paul de Souza
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e4bf37e11aa240dcac614cbaa80d6585
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4bf37e11aa240dcac614cbaa80d6585
record_format dspace
spelling oai:doaj.org-article:e4bf37e11aa240dcac614cbaa80d65852021-12-02T20:10:31ZComparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.1932-620310.1371/journal.pone.0252614https://doaj.org/article/e4bf37e11aa240dcac614cbaa80d65852021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252614https://doaj.org/toc/1932-6203<h4>Objective</h4>Pre- and post-operative neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) and other prognostic clinicopathological variables were correlated with progression free survival (PFS) and overall survival (OS) of Glioblastoma Multiforme (GBM) patients.<h4>Methods</h4>GBM patients (n = 87, single-centre, recruited 2013-2019) were retrospectively divided into low and high groups using literature-derived cut-offs (NLR = 5.07, PNI = 46.97). Kaplan-Meier survival curves and log rank tests assessed PFS and OS. Univariate and multivariate analyses identified PFS and OS prognosticators.<h4>Results</h4>High vs low post-operative PNI cohort was associated with longer PFS (279 vs 136 days, p = 0.009), but significance was lost on multivariate analysis. Post-operative ECOG (p = 0.043), daily dexamethasone (p = 0.023) and IDH mutation (p = 0.046) were significant on multivariate analysis for PFS. High pre- and post-operative PNI were associated with improved OS (384 vs 114 days, p = 0.034 and 516 vs 245 days, p = 0.001, respectively). Low postoperative NLR correlated with OS (408 vs 249 days, p = 0.029). On multivariate analysis using forward selection process, extent of resection (EOR) (GTR vs biopsy, p = 0.004 and STR vs biopsy, p = 0.011), and any previous surgery (p = 0.014) were independent prognostic biomarkers for OS. On multivariate analysis of these latter variables with literature-derived prognostic biomarkers, EOR remained significantly associated with OS (p = 0.037).<h4>Conclusions</h4>EOR, followed by having any surgery prior to GBM, are the most significant independent predictors of GBM patient's OS. Post-operative ECOG, daily dexamethasone and IDH mutation are independent prognostic biomarkers for PFS. PNI may be superior to NLR. Post- vs pre-operative serum inflammatory marker levels may be associated with survival.Celine GarrettTherese M BeckerDavid LynchJoseph PoWei XuanKieran F ScottPaul de SouzaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0252614 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Celine Garrett
Therese M Becker
David Lynch
Joseph Po
Wei Xuan
Kieran F Scott
Paul de Souza
Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
description <h4>Objective</h4>Pre- and post-operative neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) and other prognostic clinicopathological variables were correlated with progression free survival (PFS) and overall survival (OS) of Glioblastoma Multiforme (GBM) patients.<h4>Methods</h4>GBM patients (n = 87, single-centre, recruited 2013-2019) were retrospectively divided into low and high groups using literature-derived cut-offs (NLR = 5.07, PNI = 46.97). Kaplan-Meier survival curves and log rank tests assessed PFS and OS. Univariate and multivariate analyses identified PFS and OS prognosticators.<h4>Results</h4>High vs low post-operative PNI cohort was associated with longer PFS (279 vs 136 days, p = 0.009), but significance was lost on multivariate analysis. Post-operative ECOG (p = 0.043), daily dexamethasone (p = 0.023) and IDH mutation (p = 0.046) were significant on multivariate analysis for PFS. High pre- and post-operative PNI were associated with improved OS (384 vs 114 days, p = 0.034 and 516 vs 245 days, p = 0.001, respectively). Low postoperative NLR correlated with OS (408 vs 249 days, p = 0.029). On multivariate analysis using forward selection process, extent of resection (EOR) (GTR vs biopsy, p = 0.004 and STR vs biopsy, p = 0.011), and any previous surgery (p = 0.014) were independent prognostic biomarkers for OS. On multivariate analysis of these latter variables with literature-derived prognostic biomarkers, EOR remained significantly associated with OS (p = 0.037).<h4>Conclusions</h4>EOR, followed by having any surgery prior to GBM, are the most significant independent predictors of GBM patient's OS. Post-operative ECOG, daily dexamethasone and IDH mutation are independent prognostic biomarkers for PFS. PNI may be superior to NLR. Post- vs pre-operative serum inflammatory marker levels may be associated with survival.
format article
author Celine Garrett
Therese M Becker
David Lynch
Joseph Po
Wei Xuan
Kieran F Scott
Paul de Souza
author_facet Celine Garrett
Therese M Becker
David Lynch
Joseph Po
Wei Xuan
Kieran F Scott
Paul de Souza
author_sort Celine Garrett
title Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
title_short Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
title_full Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
title_fullStr Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
title_full_unstemmed Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
title_sort comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/e4bf37e11aa240dcac614cbaa80d6585
work_keys_str_mv AT celinegarrett comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT theresembecker comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT davidlynch comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT josephpo comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT weixuan comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT kieranfscott comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
AT pauldesouza comparisonofneutrophiltolymphocyteratioandprognosticnutritionalindexwithotherclinicalandmolecularbiomarkersforpredictionofglioblastomamultiformeoutcome
_version_ 1718375032526209024